A Simpler Path to Important Protection
Pneumococcal vaccines protect against Streptococcus pneumoniae infections — including pneumonia, bloodstream infections, meningitis, and ear infections. For older adults and people with certain conditions, these are some of the most important vaccines to receive — but for years, the schedule was confusing enough that many eligible adults didn't get vaccinated or got incomplete protection.
The CDC's recent updates have substantially simplified pneumococcal vaccination for most adults. The new options — particularly PCV20 — make it easier to get full protection in fewer visits.
At Zimmer Medical Group, we discuss pneumococcal vaccination with appropriate patients and ensure their schedules align with current recommendations. See our 2026 adult vaccine checklist for the broader vaccine landscape.
What Pneumococcal Disease Causes
Streptococcus pneumoniae causes:
Common Infections
- Pneumonia (most commonly)
- Sinusitis
- Otitis media
- Bronchitis
Invasive Disease
- Bacteremia (bloodstream infection)
- Meningitis
- Endocarditis
- Empyema
Invasive pneumococcal disease has substantial mortality, particularly in older adults and immunocompromised patients. Even non-invasive pneumococcal pneumonia carries risk and frequently requires hospitalization.
The Vaccine Types
Several pneumococcal vaccines exist with different mechanisms and coverage:
PPSV23 (Pneumovax 23)
- Polysaccharide vaccine — covers 23 serotypes
- Long-standing vaccine
- Generates antibody response but not strong immune memory
- Booster dosing has been part of historical schedules
PCV13 (Prevnar 13)
- Conjugate vaccine — covers 13 serotypes
- Generates strong immune memory
- Originally for children; expanded to adult use
- Now being phased out in favor of newer conjugate vaccines
PCV15 (Vaxneuvance)
- Conjugate vaccine covering 15 serotypes
- The 13 serotypes in PCV13 plus 2 additional
- Approved for adult use
PCV20 (Prevnar 20)
- Conjugate vaccine covering 20 serotypes
- Includes the most prevalent serotypes causing adult disease
- Single-dose option for many adults
- Often the simplest choice
PCV21 (Capvaxive)
- Newest conjugate vaccine specifically designed for adult disease
- Covers 21 serotypes
- Specifically targets serotypes most relevant to adult infections
- May become preferred for adults as it becomes more widely used
Current Recommendations (Simplified)
The CDC recommendations have been significantly simplified. The basic framework:
Adults 50 and Older
The 2024 CDC update lowered the universal recommendation from 65 to 50:
- Adults 50 and older who have not received any pneumococcal vaccine
- Should receive either PCV20 (or PCV21) — single dose
- OR PCV15 followed by PPSV23 at least 1 year later
PCV20/PCV21 single-dose option is simpler and often preferred.
Adults 19–49 with Risk Factors
Risk-based vaccination for adults 19–49 with:
- Chronic heart, lung, liver, or kidney disease
- Diabetes
- Cigarette smoking
- Cochlear implants
- Cerebrospinal fluid leaks
- Asplenia (no spleen)
- Sickle cell disease
- Immunocompromising conditions
- Generalized malignancy
- HIV
- Chronic alcohol use
- Solid organ or stem cell transplant
- Hematologic malignancies
Special Considerations for Immunocompromised Patients
Immunocompromised patients may have additional dosing requirements and may benefit from both PCV and PPSV23. The exact schedule depends on the specific condition.
Patients Who Have Received Older Schedules
For patients who have already had vaccines under previous recommendations, the path forward depends on what was received:
Previously Received PCV13 Only
- Generally complete the schedule with PPSV23 at appropriate interval
- Discuss whether additional newer vaccines are recommended
Previously Received PPSV23 Only
- May benefit from a conjugate vaccine (PCV20 or PCV21)
- Specific timing depends on individual situation
Previously Received Both PCV13 and PPSV23
- Generally considered to have completed the basic series
- Newer recommendations may apply for some patients
The simplest approach: discuss your prior vaccinations with your doctor to determine the best next step.
Why Pneumococcal Vaccination Matters
The case for pneumococcal vaccination is strong:
- Pneumococcal pneumonia is a leading cause of hospitalization in older adults
- Invasive pneumococcal disease has high mortality
- Antibiotic resistance is rising, making prevention more important
- Vaccination substantially reduces both incidence and severity
- Often coincides with respiratory virus season when other infections are also circulating
Combining With Other Vaccines
Pneumococcal vaccines can be given the same day as other vaccines. Common combinations:
- Pneumococcal plus influenza
- Pneumococcal plus shingles (shingles)
- Pneumococcal plus RSV (for eligible patients)
- Pneumococcal plus Tdap
This is convenient and well-supported by evidence.
Common Side Effects
Pneumococcal vaccines are generally well-tolerated. Common reactions:
- Soreness, redness, or swelling at the injection site
- Mild fever
- Muscle aches
- Fatigue
- Generally resolve within 1–2 days
Serious reactions are rare. The vaccine cannot cause pneumococcal infection.
Special Populations
Adults Over 65
Universal recommendation. Most patients in this age group benefit substantially.
Patients with Diabetes
Risk for pneumococcal disease is significantly elevated. Vaccination is particularly important.
Patients with COPD or Chronic Lung Disease
High-risk group; vaccination strongly recommended.
Smokers
Even without other risk factors, smoking elevates pneumococcal disease risk substantially. Vaccination at younger ages is recommended.
Patients with No Spleen (Asplenia)
Particularly high risk for pneumococcal sepsis. Vaccination is essential and may include additional doses.
Immunocompromised Patients
Including HIV, transplant recipients, those on immunosuppressive therapy, hematologic malignancies. Vaccination is particularly important and schedules may be more complex.
Patients with Cochlear Implants
Specific recommendation due to risk of meningitis.
Practical Considerations
Insurance Coverage
- Pneumococcal vaccines are covered by Medicare Part B (no deductible, no copay)
- Most commercial insurance plans cover at no cost as preventive care under ACA
- Vaccines for Children program covers pediatric doses
Where to Get Vaccinated
- Primary care offices
- Pharmacies (most chain pharmacies offer pneumococcal vaccines)
- Health departments
- Some specialty offices
Documentation
- Keep vaccine records
- Many states have immunization registries that track vaccines
- Bring records to medical appointments
Common Patient Questions
"I had pneumonia last year. Do I still need the vaccine?"
Yes. The vaccine protects against pneumococcal pneumonia specifically — many pneumonias are caused by other pathogens. Even if your previous pneumonia was pneumococcal, you can still get it again.
"I never get sick. Do I really need this?"
Pneumococcal disease can occur in healthy people, particularly with age. The complications can be severe enough that prevention is worthwhile even for healthy adults at the appropriate age.
"I'm scared of vaccine side effects."
Pneumococcal vaccines have an excellent safety record. Most reactions are mild and self-limited. Discuss specific concerns with your doctor.
"My friend got it and still got pneumonia."
No vaccine is 100 percent effective, and pneumonia can be caused by many pathogens not covered by pneumococcal vaccines. The vaccines reduce risk and severity but don't eliminate possibility entirely.
When to See Your Doctor
- Approaching age 50 (the new universal recommendation threshold)
- Risk factors warranting earlier vaccination
- Prior pneumococcal disease
- Immunocompromising conditions
- Confusion about which vaccines you've received and what's needed next
- Coordination with other vaccines (influenza, RSV, shingles)
The CDC Pneumococcal Vaccination page provides authoritative current recommendations.
Approaching 50 or have risk factors for pneumococcal disease? Contact Zimmer Medical Group to discuss the current vaccine options and ensure you're up to date with this important protection.
